Adage Capital Partners
NKGN

Adage Capital Partners’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Adage Capital Partners’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,350,000
Closed -$13.7M – 948
2023
Q1 		$13.7M Hold
1,350,000
– – 0.03% 539
2022
Q4 		$13.4M Hold
1,350,000
– – 0.03% 554
2022
Q3 		$13.2M Hold
1,350,000
– – 0.03% 560
2022
Q2 		$13.1M Hold
1,350,000
– – 0.03% 592
2022
Q1 		$13.1M Hold
1,350,000
– – 0.02% 615
2021
Q4 		$13.1M Hold
1,350,000
– – 0.02% 620
2021
Q3 		$13.1M Buy
+1,350,000
New +$13.2M 0.03% 615

Other funds holding NKGN

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $5.03M AUM 3.16% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $574M AUM 6.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $678M AUM 0.91% 1-Year Est. Return